DVONCH JEROME J enters SONOMA PHARMACEUTICALS, INC. with 31.01K shares plus derivative instruments
Holding both equity and derivatives at entry signals strong long-term conviction in the company.
Direct Derivatives
Filed: 4/13/2023ACC: 0001683168-23-002360
Officer· Chief Financial Officer
Since Sep 2020
31.01K
Baseline shares
100% direct
31.01K
Direct ownership
1 position
57.78K
Derivative underlying
2 instruments
1
Security positions
All direct
Non-Derivative Holdings1
Common Stock
DirectShares owned31.01K
Total
31.01K direct31.01K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 31.01K | Direct |
| Total | 31.01K | 31.01K direct |
Derivative Holdings2
Stock option (right to buy)
DirectUnderlying security
Common Stock
Underlying shares
27.78K
Shares owned
N/A
Exercise price
8.03
Expiration
—
Exercise window
—
Stock option (right to buy)
DirectUnderlying security
Common Stock
Underlying shares
30K
Shares owned
N/A
Exercise price
4.6
Expiration
—
Exercise window
—
Total
Underlying
57.78K
Owned
0.00
| Security | Underlying | Exercise Price | Exercise Window | Expiration | Underlying Shares | Shares Owned |
|---|---|---|---|---|---|---|
| Stock option (right to buy) Direct | Common Stock | 8.03 | — | — | 27.78K | N/A |
| Stock option (right to buy) Direct | Common Stock | 4.6 | — | — | 30K | N/A |
| Total | 57.78K | 0.00 | ||||